Global Small Interfering RNA (siRNA) Drugs Market Growth (Status and Outlook) 2026-2032
The global Small Interfering RNA (siRNA) Drugs market size is predicted to grow from US$ 2498 million in 2025 to US$ 14030 million in 2032; it is expected to grow at a CAGR of 28.5% from 2026 to 2032.
Small Interfering RNA (siRNA) drugs are a class of nucleic acid-based therapeutics that utilize short RNA molecules to silence or regulate the expression of specific genes. These drugs have the ability to interfere with the translation of messenger RNA (mRNA) into proteins, effectively "silencing" the gene associated with that mRNA. SiRNA-based therapies have the potential to treat a variety of diseases, particularly those with a genetic or RNA-based component.
The Small Interfering RNA (siRNA) Drugs Market is driven by the transformative potential of siRNA-based therapies in silencing disease-associated genes, making them a promising approach for treating a wide range of diseases, including genetic disorders, viral infections, and various cancers. siRNA drugs work by selectively degrading or inhibiting the expression of specific genes, offering a highly targeted and personalized treatment option. As the understanding of genomics and RNA interference mechanisms advances, and the need for precision medicine grows, the demand for siRNA drugs continues to rise. Innovations in siRNA design, delivery systems, and gene-editing technologies further contribute to market expansion. However, a significant challenge for this market is the need to overcome delivery barriers, ensure the stability and safety of siRNA therapeutics, and navigate regulatory complexities. Addressing off-target effects, optimizing pharmacokinetics, and managing the high cost of siRNA drug development are ongoing challenges. Additionally, the market faces competition from traditional therapeutic approaches and the need for continuous research and development to unlock the full therapeutic potential of siRNA drugs. Striking a balance between providing safe, effective, and accessible siRNA therapies while addressing scientific and regulatory challenges is essential for the continued growth of the Small Interfering RNA (siRNA) Drugs Market.
LPI (LP Information)' newest research report, the “Small Interfering RNA (siRNA) Drugs Industry Forecast” looks at past sales and reviews total world Small Interfering RNA (siRNA) Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Small Interfering RNA (siRNA) Drugs sales for 2026 through 2032. With Small Interfering RNA (siRNA) Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Small Interfering RNA (siRNA) Drugs industry.
This Insight Report provides a comprehensive analysis of the global Small Interfering RNA (siRNA) Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Small Interfering RNA (siRNA) Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Small Interfering RNA (siRNA) Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Small Interfering RNA (siRNA) Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Small Interfering RNA (siRNA) Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Small Interfering RNA (siRNA) Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
Small Interfering RNA (siRNA) drugs are a class of nucleic acid-based therapeutics that utilize short RNA molecules to silence or regulate the expression of specific genes. These drugs have the ability to interfere with the translation of messenger RNA (mRNA) into proteins, effectively "silencing" the gene associated with that mRNA. SiRNA-based therapies have the potential to treat a variety of diseases, particularly those with a genetic or RNA-based component.
The Small Interfering RNA (siRNA) Drugs Market is driven by the transformative potential of siRNA-based therapies in silencing disease-associated genes, making them a promising approach for treating a wide range of diseases, including genetic disorders, viral infections, and various cancers. siRNA drugs work by selectively degrading or inhibiting the expression of specific genes, offering a highly targeted and personalized treatment option. As the understanding of genomics and RNA interference mechanisms advances, and the need for precision medicine grows, the demand for siRNA drugs continues to rise. Innovations in siRNA design, delivery systems, and gene-editing technologies further contribute to market expansion. However, a significant challenge for this market is the need to overcome delivery barriers, ensure the stability and safety of siRNA therapeutics, and navigate regulatory complexities. Addressing off-target effects, optimizing pharmacokinetics, and managing the high cost of siRNA drug development are ongoing challenges. Additionally, the market faces competition from traditional therapeutic approaches and the need for continuous research and development to unlock the full therapeutic potential of siRNA drugs. Striking a balance between providing safe, effective, and accessible siRNA therapies while addressing scientific and regulatory challenges is essential for the continued growth of the Small Interfering RNA (siRNA) Drugs Market.
LPI (LP Information)' newest research report, the “Small Interfering RNA (siRNA) Drugs Industry Forecast” looks at past sales and reviews total world Small Interfering RNA (siRNA) Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Small Interfering RNA (siRNA) Drugs sales for 2026 through 2032. With Small Interfering RNA (siRNA) Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Small Interfering RNA (siRNA) Drugs industry.
This Insight Report provides a comprehensive analysis of the global Small Interfering RNA (siRNA) Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Small Interfering RNA (siRNA) Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Small Interfering RNA (siRNA) Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Small Interfering RNA (siRNA) Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Small Interfering RNA (siRNA) Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Small Interfering RNA (siRNA) Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
- GIVLAARI
- Onpattro
- OXLUMO
- AMVUTTRA
- Leqvio
- AHP
- hATTR
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Alnylam
- Novartis
- Sylentis
- Arrowhead
- Silence Therapeutics
- Dicerna
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Small Interfering RNA (siRNA) Drugs Market Size (2021-2032)
2.1.2 Small Interfering RNA (siRNA) Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Small Interfering RNA (siRNA) Drugs by Country/Region (2021, 2025 & 2032)
2.2 Small Interfering RNA (siRNA) Drugs Segment by Type
2.2.1 GIVLAARI
2.2.2 Onpattro
2.2.3 OXLUMO
2.2.4 AMVUTTRA
2.2.5 Leqvio
2.2.6 Small Interfering RNA (siRNA) Drugs Market Size by Type
2.2.6.1 Small Interfering RNA (siRNA) Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global Small Interfering RNA (siRNA) Drugs Market Size Market Share by Type (2021-2026)
2.3 Small Interfering RNA (siRNA) Drugs Segment by Application
2.3.1 AHP
2.3.2 hATTR
2.3.3 Other
2.3.4 Small Interfering RNA (siRNA) Drugs Market Size by Application
2.3.4.1 Small Interfering RNA (siRNA) Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Small Interfering RNA (siRNA) Drugs Market Size Market Share by Application (2021-2026)
3 SMALL INTERFERING RNA (SIRNA) DRUGS MARKET SIZE BY PLAYER
3.1 Small Interfering RNA (siRNA) Drugs Market Size Market Share by Player
3.1.1 Global Small Interfering RNA (siRNA) Drugs Revenue by Player (2021-2026)
3.1.2 Global Small Interfering RNA (siRNA) Drugs Revenue Market Share by Player (2021-2026)
3.2 Global Small Interfering RNA (siRNA) Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SMALL INTERFERING RNA (SIRNA) DRUGS BY REGION
4.1 Small Interfering RNA (siRNA) Drugs Market Size by Region (2021-2026)
4.2 Global Small Interfering RNA (siRNA) Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Small Interfering RNA (siRNA) Drugs Market Size Growth (2021-2026)
4.4 APAC Small Interfering RNA (siRNA) Drugs Market Size Growth (2021-2026)
4.5 Europe Small Interfering RNA (siRNA) Drugs Market Size Growth (2021-2026)
4.6 Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Small Interfering RNA (siRNA) Drugs Market Size by Country (2021-2026)
5.2 Americas Small Interfering RNA (siRNA) Drugs Market Size by Type (2021-2026)
5.3 Americas Small Interfering RNA (siRNA) Drugs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Small Interfering RNA (siRNA) Drugs Market Size by Region (2021-2026)
6.2 APAC Small Interfering RNA (siRNA) Drugs Market Size by Type (2021-2026)
6.3 APAC Small Interfering RNA (siRNA) Drugs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Small Interfering RNA (siRNA) Drugs Market Size by Country (2021-2026)
7.2 Europe Small Interfering RNA (siRNA) Drugs Market Size by Type (2021-2026)
7.3 Europe Small Interfering RNA (siRNA) Drugs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Small Interfering RNA (siRNA) Drugs by Region (2021-2026)
8.2 Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size by Type (2021-2026)
8.3 Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SMALL INTERFERING RNA (SIRNA) DRUGS MARKET FORECAST
10.1 Global Small Interfering RNA (siRNA) Drugs Forecast by Region (2027-2032)
10.1.1 Global Small Interfering RNA (siRNA) Drugs Forecast by Region (2027-2032)
10.1.2 Americas Small Interfering RNA (siRNA) Drugs Forecast
10.1.3 APAC Small Interfering RNA (siRNA) Drugs Forecast
10.1.4 Europe Small Interfering RNA (siRNA) Drugs Forecast
10.1.5 Middle East & Africa Small Interfering RNA (siRNA) Drugs Forecast
10.2 Americas Small Interfering RNA (siRNA) Drugs Forecast by Country (2027-2032)
10.2.1 United States Market Small Interfering RNA (siRNA) Drugs Forecast
10.2.2 Canada Market Small Interfering RNA (siRNA) Drugs Forecast
10.2.3 Mexico Market Small Interfering RNA (siRNA) Drugs Forecast
10.2.4 Brazil Market Small Interfering RNA (siRNA) Drugs Forecast
10.3 APAC Small Interfering RNA (siRNA) Drugs Forecast by Region (2027-2032)
10.3.1 China Small Interfering RNA (siRNA) Drugs Market Forecast
10.3.2 Japan Market Small Interfering RNA (siRNA) Drugs Forecast
10.3.3 Korea Market Small Interfering RNA (siRNA) Drugs Forecast
10.3.4 Southeast Asia Market Small Interfering RNA (siRNA) Drugs Forecast
10.3.5 India Market Small Interfering RNA (siRNA) Drugs Forecast
10.3.6 Australia Market Small Interfering RNA (siRNA) Drugs Forecast
10.4 Europe Small Interfering RNA (siRNA) Drugs Forecast by Country (2027-2032)
10.4.1 Germany Market Small Interfering RNA (siRNA) Drugs Forecast
10.4.2 France Market Small Interfering RNA (siRNA) Drugs Forecast
10.4.3 UK Market Small Interfering RNA (siRNA) Drugs Forecast
10.4.4 Italy Market Small Interfering RNA (siRNA) Drugs Forecast
10.4.5 Russia Market Small Interfering RNA (siRNA) Drugs Forecast
10.5 Middle East & Africa Small Interfering RNA (siRNA) Drugs Forecast by Region (2027-2032)
10.5.1 Egypt Market Small Interfering RNA (siRNA) Drugs Forecast
10.5.2 South Africa Market Small Interfering RNA (siRNA) Drugs Forecast
10.5.3 Israel Market Small Interfering RNA (siRNA) Drugs Forecast
10.5.4 Turkey Market Small Interfering RNA (siRNA) Drugs Forecast
10.6 Global Small Interfering RNA (siRNA) Drugs Forecast by Type (2027-2032)
10.7 Global Small Interfering RNA (siRNA) Drugs Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Small Interfering RNA (siRNA) Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Alnylam
11.1.1 Alnylam Company Information
11.1.2 Alnylam Small Interfering RNA (siRNA) Drugs Product Offered
11.1.3 Alnylam Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Alnylam Main Business Overview
11.1.5 Alnylam Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Small Interfering RNA (siRNA) Drugs Product Offered
11.2.3 Novartis Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Sylentis
11.3.1 Sylentis Company Information
11.3.2 Sylentis Small Interfering RNA (siRNA) Drugs Product Offered
11.3.3 Sylentis Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Sylentis Main Business Overview
11.3.5 Sylentis Latest Developments
11.4 Arrowhead
11.4.1 Arrowhead Company Information
11.4.2 Arrowhead Small Interfering RNA (siRNA) Drugs Product Offered
11.4.3 Arrowhead Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Arrowhead Main Business Overview
11.4.5 Arrowhead Latest Developments
11.5 Silence Therapeutics
11.5.1 Silence Therapeutics Company Information
11.5.2 Silence Therapeutics Small Interfering RNA (siRNA) Drugs Product Offered
11.5.3 Silence Therapeutics Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Silence Therapeutics Main Business Overview
11.5.5 Silence Therapeutics Latest Developments
11.6 Dicerna
11.6.1 Dicerna Company Information
11.6.2 Dicerna Small Interfering RNA (siRNA) Drugs Product Offered
11.6.3 Dicerna Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Dicerna Main Business Overview
11.6.5 Dicerna Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Small Interfering RNA (siRNA) Drugs Market Size (2021-2032)
2.1.2 Small Interfering RNA (siRNA) Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Small Interfering RNA (siRNA) Drugs by Country/Region (2021, 2025 & 2032)
2.2 Small Interfering RNA (siRNA) Drugs Segment by Type
2.2.1 GIVLAARI
2.2.2 Onpattro
2.2.3 OXLUMO
2.2.4 AMVUTTRA
2.2.5 Leqvio
2.2.6 Small Interfering RNA (siRNA) Drugs Market Size by Type
2.2.6.1 Small Interfering RNA (siRNA) Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global Small Interfering RNA (siRNA) Drugs Market Size Market Share by Type (2021-2026)
2.3 Small Interfering RNA (siRNA) Drugs Segment by Application
2.3.1 AHP
2.3.2 hATTR
2.3.3 Other
2.3.4 Small Interfering RNA (siRNA) Drugs Market Size by Application
2.3.4.1 Small Interfering RNA (siRNA) Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Small Interfering RNA (siRNA) Drugs Market Size Market Share by Application (2021-2026)
3 SMALL INTERFERING RNA (SIRNA) DRUGS MARKET SIZE BY PLAYER
3.1 Small Interfering RNA (siRNA) Drugs Market Size Market Share by Player
3.1.1 Global Small Interfering RNA (siRNA) Drugs Revenue by Player (2021-2026)
3.1.2 Global Small Interfering RNA (siRNA) Drugs Revenue Market Share by Player (2021-2026)
3.2 Global Small Interfering RNA (siRNA) Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SMALL INTERFERING RNA (SIRNA) DRUGS BY REGION
4.1 Small Interfering RNA (siRNA) Drugs Market Size by Region (2021-2026)
4.2 Global Small Interfering RNA (siRNA) Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Small Interfering RNA (siRNA) Drugs Market Size Growth (2021-2026)
4.4 APAC Small Interfering RNA (siRNA) Drugs Market Size Growth (2021-2026)
4.5 Europe Small Interfering RNA (siRNA) Drugs Market Size Growth (2021-2026)
4.6 Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Small Interfering RNA (siRNA) Drugs Market Size by Country (2021-2026)
5.2 Americas Small Interfering RNA (siRNA) Drugs Market Size by Type (2021-2026)
5.3 Americas Small Interfering RNA (siRNA) Drugs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Small Interfering RNA (siRNA) Drugs Market Size by Region (2021-2026)
6.2 APAC Small Interfering RNA (siRNA) Drugs Market Size by Type (2021-2026)
6.3 APAC Small Interfering RNA (siRNA) Drugs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Small Interfering RNA (siRNA) Drugs Market Size by Country (2021-2026)
7.2 Europe Small Interfering RNA (siRNA) Drugs Market Size by Type (2021-2026)
7.3 Europe Small Interfering RNA (siRNA) Drugs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Small Interfering RNA (siRNA) Drugs by Region (2021-2026)
8.2 Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size by Type (2021-2026)
8.3 Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SMALL INTERFERING RNA (SIRNA) DRUGS MARKET FORECAST
10.1 Global Small Interfering RNA (siRNA) Drugs Forecast by Region (2027-2032)
10.1.1 Global Small Interfering RNA (siRNA) Drugs Forecast by Region (2027-2032)
10.1.2 Americas Small Interfering RNA (siRNA) Drugs Forecast
10.1.3 APAC Small Interfering RNA (siRNA) Drugs Forecast
10.1.4 Europe Small Interfering RNA (siRNA) Drugs Forecast
10.1.5 Middle East & Africa Small Interfering RNA (siRNA) Drugs Forecast
10.2 Americas Small Interfering RNA (siRNA) Drugs Forecast by Country (2027-2032)
10.2.1 United States Market Small Interfering RNA (siRNA) Drugs Forecast
10.2.2 Canada Market Small Interfering RNA (siRNA) Drugs Forecast
10.2.3 Mexico Market Small Interfering RNA (siRNA) Drugs Forecast
10.2.4 Brazil Market Small Interfering RNA (siRNA) Drugs Forecast
10.3 APAC Small Interfering RNA (siRNA) Drugs Forecast by Region (2027-2032)
10.3.1 China Small Interfering RNA (siRNA) Drugs Market Forecast
10.3.2 Japan Market Small Interfering RNA (siRNA) Drugs Forecast
10.3.3 Korea Market Small Interfering RNA (siRNA) Drugs Forecast
10.3.4 Southeast Asia Market Small Interfering RNA (siRNA) Drugs Forecast
10.3.5 India Market Small Interfering RNA (siRNA) Drugs Forecast
10.3.6 Australia Market Small Interfering RNA (siRNA) Drugs Forecast
10.4 Europe Small Interfering RNA (siRNA) Drugs Forecast by Country (2027-2032)
10.4.1 Germany Market Small Interfering RNA (siRNA) Drugs Forecast
10.4.2 France Market Small Interfering RNA (siRNA) Drugs Forecast
10.4.3 UK Market Small Interfering RNA (siRNA) Drugs Forecast
10.4.4 Italy Market Small Interfering RNA (siRNA) Drugs Forecast
10.4.5 Russia Market Small Interfering RNA (siRNA) Drugs Forecast
10.5 Middle East & Africa Small Interfering RNA (siRNA) Drugs Forecast by Region (2027-2032)
10.5.1 Egypt Market Small Interfering RNA (siRNA) Drugs Forecast
10.5.2 South Africa Market Small Interfering RNA (siRNA) Drugs Forecast
10.5.3 Israel Market Small Interfering RNA (siRNA) Drugs Forecast
10.5.4 Turkey Market Small Interfering RNA (siRNA) Drugs Forecast
10.6 Global Small Interfering RNA (siRNA) Drugs Forecast by Type (2027-2032)
10.7 Global Small Interfering RNA (siRNA) Drugs Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Small Interfering RNA (siRNA) Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Alnylam
11.1.1 Alnylam Company Information
11.1.2 Alnylam Small Interfering RNA (siRNA) Drugs Product Offered
11.1.3 Alnylam Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Alnylam Main Business Overview
11.1.5 Alnylam Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Small Interfering RNA (siRNA) Drugs Product Offered
11.2.3 Novartis Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Sylentis
11.3.1 Sylentis Company Information
11.3.2 Sylentis Small Interfering RNA (siRNA) Drugs Product Offered
11.3.3 Sylentis Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Sylentis Main Business Overview
11.3.5 Sylentis Latest Developments
11.4 Arrowhead
11.4.1 Arrowhead Company Information
11.4.2 Arrowhead Small Interfering RNA (siRNA) Drugs Product Offered
11.4.3 Arrowhead Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Arrowhead Main Business Overview
11.4.5 Arrowhead Latest Developments
11.5 Silence Therapeutics
11.5.1 Silence Therapeutics Company Information
11.5.2 Silence Therapeutics Small Interfering RNA (siRNA) Drugs Product Offered
11.5.3 Silence Therapeutics Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Silence Therapeutics Main Business Overview
11.5.5 Silence Therapeutics Latest Developments
11.6 Dicerna
11.6.1 Dicerna Company Information
11.6.2 Dicerna Small Interfering RNA (siRNA) Drugs Product Offered
11.6.3 Dicerna Small Interfering RNA (siRNA) Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Dicerna Main Business Overview
11.6.5 Dicerna Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Small Interfering RNA (siRNA) Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Small Interfering RNA (siRNA) Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of GIVLAARI
Table 4. Major Players of Onpattro
Table 5. Major Players of OXLUMO
Table 6. Major Players of AMVUTTRA
Table 7. Major Players of Leqvio
Table 8. Small Interfering RNA (siRNA) Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Small Interfering RNA (siRNA) Drugs Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Small Interfering RNA (siRNA) Drugs Market Size Market Share by Type (2021-2026)
Table 11. Small Interfering RNA (siRNA) Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Small Interfering RNA (siRNA) Drugs Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Small Interfering RNA (siRNA) Drugs Market Size Market Share by Application (2021-2026)
Table 14. Global Small Interfering RNA (siRNA) Drugs Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Small Interfering RNA (siRNA) Drugs Revenue Market Share by Player (2021-2026)
Table 16. Small Interfering RNA (siRNA) Drugs Key Players Head office and Products Offered
Table 17. Small Interfering RNA (siRNA) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Small Interfering RNA (siRNA) Drugs Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Small Interfering RNA (siRNA) Drugs Market Size Market Share by Region (2021-2026)
Table 22. Global Small Interfering RNA (siRNA) Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Small Interfering RNA (siRNA) Drugs Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Small Interfering RNA (siRNA) Drugs Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Small Interfering RNA (siRNA) Drugs Market Size Market Share by Country (2021-2026)
Table 26. Americas Small Interfering RNA (siRNA) Drugs Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Small Interfering RNA (siRNA) Drugs Market Size Market Share by Type (2021-2026)
Table 28. Americas Small Interfering RNA (siRNA) Drugs Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Small Interfering RNA (siRNA) Drugs Market Size Market Share by Application (2021-2026)
Table 30. APAC Small Interfering RNA (siRNA) Drugs Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Small Interfering RNA (siRNA) Drugs Market Size Market Share by Region (2021-2026)
Table 32. APAC Small Interfering RNA (siRNA) Drugs Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Small Interfering RNA (siRNA) Drugs Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Small Interfering RNA (siRNA) Drugs Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Small Interfering RNA (siRNA) Drugs Market Size Market Share by Country (2021-2026)
Table 36. Europe Small Interfering RNA (siRNA) Drugs Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Small Interfering RNA (siRNA) Drugs Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Small Interfering RNA (siRNA) Drugs
Table 42. Key Market Challenges & Risks of Small Interfering RNA (siRNA) Drugs
Table 43. Key Industry Trends of Small Interfering RNA (siRNA) Drugs
Table 44. Global Small Interfering RNA (siRNA) Drugs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Small Interfering RNA (siRNA) Drugs Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Small Interfering RNA (siRNA) Drugs Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Small Interfering RNA (siRNA) Drugs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. Alnylam Details, Company Type, Small Interfering RNA (siRNA) Drugs Area Served and Its Competitors
Table 49. Alnylam Small Interfering RNA (siRNA) Drugs Product Offered
Table 50. Alnylam Small Interfering RNA (siRNA) Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. Alnylam Main Business
Table 52. Alnylam Latest Developments
Table 53. Novartis Details, Company Type, Small Interfering RNA (siRNA) Drugs Area Served and Its Competitors
Table 54. Novartis Small Interfering RNA (siRNA) Drugs Product Offered
Table 55. Novartis Small Interfering RNA (siRNA) Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. Novartis Main Business
Table 57. Novartis Latest Developments
Table 58. Sylentis Details, Company Type, Small Interfering RNA (siRNA) Drugs Area Served and Its Competitors
Table 59. Sylentis Small Interfering RNA (siRNA) Drugs Product Offered
Table 60. Sylentis Small Interfering RNA (siRNA) Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Sylentis Main Business
Table 62. Sylentis Latest Developments
Table 63. Arrowhead Details, Company Type, Small Interfering RNA (siRNA) Drugs Area Served and Its Competitors
Table 64. Arrowhead Small Interfering RNA (siRNA) Drugs Product Offered
Table 65. Arrowhead Small Interfering RNA (siRNA) Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Arrowhead Main Business
Table 67. Arrowhead Latest Developments
Table 68. Silence Therapeutics Details, Company Type, Small Interfering RNA (siRNA) Drugs Area Served and Its Competitors
Table 69. Silence Therapeutics Small Interfering RNA (siRNA) Drugs Product Offered
Table 70. Silence Therapeutics Small Interfering RNA (siRNA) Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Silence Therapeutics Main Business
Table 72. Silence Therapeutics Latest Developments
Table 73. Dicerna Details, Company Type, Small Interfering RNA (siRNA) Drugs Area Served and Its Competitors
Table 74. Dicerna Small Interfering RNA (siRNA) Drugs Product Offered
Table 75. Dicerna Small Interfering RNA (siRNA) Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Dicerna Main Business
Table 77. Dicerna Latest Developments
Table 1. Small Interfering RNA (siRNA) Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Small Interfering RNA (siRNA) Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of GIVLAARI
Table 4. Major Players of Onpattro
Table 5. Major Players of OXLUMO
Table 6. Major Players of AMVUTTRA
Table 7. Major Players of Leqvio
Table 8. Small Interfering RNA (siRNA) Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Small Interfering RNA (siRNA) Drugs Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Small Interfering RNA (siRNA) Drugs Market Size Market Share by Type (2021-2026)
Table 11. Small Interfering RNA (siRNA) Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Small Interfering RNA (siRNA) Drugs Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Small Interfering RNA (siRNA) Drugs Market Size Market Share by Application (2021-2026)
Table 14. Global Small Interfering RNA (siRNA) Drugs Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Small Interfering RNA (siRNA) Drugs Revenue Market Share by Player (2021-2026)
Table 16. Small Interfering RNA (siRNA) Drugs Key Players Head office and Products Offered
Table 17. Small Interfering RNA (siRNA) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Small Interfering RNA (siRNA) Drugs Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Small Interfering RNA (siRNA) Drugs Market Size Market Share by Region (2021-2026)
Table 22. Global Small Interfering RNA (siRNA) Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Small Interfering RNA (siRNA) Drugs Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Small Interfering RNA (siRNA) Drugs Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Small Interfering RNA (siRNA) Drugs Market Size Market Share by Country (2021-2026)
Table 26. Americas Small Interfering RNA (siRNA) Drugs Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Small Interfering RNA (siRNA) Drugs Market Size Market Share by Type (2021-2026)
Table 28. Americas Small Interfering RNA (siRNA) Drugs Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Small Interfering RNA (siRNA) Drugs Market Size Market Share by Application (2021-2026)
Table 30. APAC Small Interfering RNA (siRNA) Drugs Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Small Interfering RNA (siRNA) Drugs Market Size Market Share by Region (2021-2026)
Table 32. APAC Small Interfering RNA (siRNA) Drugs Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Small Interfering RNA (siRNA) Drugs Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Small Interfering RNA (siRNA) Drugs Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Small Interfering RNA (siRNA) Drugs Market Size Market Share by Country (2021-2026)
Table 36. Europe Small Interfering RNA (siRNA) Drugs Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Small Interfering RNA (siRNA) Drugs Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Small Interfering RNA (siRNA) Drugs
Table 42. Key Market Challenges & Risks of Small Interfering RNA (siRNA) Drugs
Table 43. Key Industry Trends of Small Interfering RNA (siRNA) Drugs
Table 44. Global Small Interfering RNA (siRNA) Drugs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Small Interfering RNA (siRNA) Drugs Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Small Interfering RNA (siRNA) Drugs Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Small Interfering RNA (siRNA) Drugs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. Alnylam Details, Company Type, Small Interfering RNA (siRNA) Drugs Area Served and Its Competitors
Table 49. Alnylam Small Interfering RNA (siRNA) Drugs Product Offered
Table 50. Alnylam Small Interfering RNA (siRNA) Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. Alnylam Main Business
Table 52. Alnylam Latest Developments
Table 53. Novartis Details, Company Type, Small Interfering RNA (siRNA) Drugs Area Served and Its Competitors
Table 54. Novartis Small Interfering RNA (siRNA) Drugs Product Offered
Table 55. Novartis Small Interfering RNA (siRNA) Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. Novartis Main Business
Table 57. Novartis Latest Developments
Table 58. Sylentis Details, Company Type, Small Interfering RNA (siRNA) Drugs Area Served and Its Competitors
Table 59. Sylentis Small Interfering RNA (siRNA) Drugs Product Offered
Table 60. Sylentis Small Interfering RNA (siRNA) Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Sylentis Main Business
Table 62. Sylentis Latest Developments
Table 63. Arrowhead Details, Company Type, Small Interfering RNA (siRNA) Drugs Area Served and Its Competitors
Table 64. Arrowhead Small Interfering RNA (siRNA) Drugs Product Offered
Table 65. Arrowhead Small Interfering RNA (siRNA) Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Arrowhead Main Business
Table 67. Arrowhead Latest Developments
Table 68. Silence Therapeutics Details, Company Type, Small Interfering RNA (siRNA) Drugs Area Served and Its Competitors
Table 69. Silence Therapeutics Small Interfering RNA (siRNA) Drugs Product Offered
Table 70. Silence Therapeutics Small Interfering RNA (siRNA) Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Silence Therapeutics Main Business
Table 72. Silence Therapeutics Latest Developments
Table 73. Dicerna Details, Company Type, Small Interfering RNA (siRNA) Drugs Area Served and Its Competitors
Table 74. Dicerna Small Interfering RNA (siRNA) Drugs Product Offered
Table 75. Dicerna Small Interfering RNA (siRNA) Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Dicerna Main Business
Table 77. Dicerna Latest Developments
LIST OF FIGURES
Figure 1. Small Interfering RNA (siRNA) Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Small Interfering RNA (siRNA) Drugs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Small Interfering RNA (siRNA) Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Small Interfering RNA (siRNA) Drugs Sales Market Share by Country/Region (2025)
Figure 8. Small Interfering RNA (siRNA) Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Small Interfering RNA (siRNA) Drugs Market Size Market Share by Type in 2025
Figure 10. Small Interfering RNA (siRNA) Drugs in AHP
Figure 11. Global Small Interfering RNA (siRNA) Drugs Market: AHP (2021-2026) & ($ millions)
Figure 12. Small Interfering RNA (siRNA) Drugs in hATTR
Figure 13. Global Small Interfering RNA (siRNA) Drugs Market: hATTR (2021-2026) & ($ millions)
Figure 14. Small Interfering RNA (siRNA) Drugs in Other
Figure 15. Global Small Interfering RNA (siRNA) Drugs Market: Other (2021-2026) & ($ millions)
Figure 16. Global Small Interfering RNA (siRNA) Drugs Market Size Market Share by Application in 2025
Figure 17. Global Small Interfering RNA (siRNA) Drugs Revenue Market Share by Player in 2025
Figure 18. Global Small Interfering RNA (siRNA) Drugs Market Size Market Share by Region (2021-2026)
Figure 19. Americas Small Interfering RNA (siRNA) Drugs Market Size 2021-2026 ($ millions)
Figure 20. APAC Small Interfering RNA (siRNA) Drugs Market Size 2021-2026 ($ millions)
Figure 21. Europe Small Interfering RNA (siRNA) Drugs Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size 2021-2026 ($ millions)
Figure 23. Americas Small Interfering RNA (siRNA) Drugs Value Market Share by Country in 2025
Figure 24. United States Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Small Interfering RNA (siRNA) Drugs Market Size Market Share by Region in 2025
Figure 29. APAC Small Interfering RNA (siRNA) Drugs Market Size Market Share by Type (2021-2026)
Figure 30. APAC Small Interfering RNA (siRNA) Drugs Market Size Market Share by Application (2021-2026)
Figure 31. China Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 35. India Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Small Interfering RNA (siRNA) Drugs Market Size Market Share by Country in 2025
Figure 38. Europe Small Interfering RNA (siRNA) Drugs Market Size Market Share by Type (2021-2026)
Figure 39. Europe Small Interfering RNA (siRNA) Drugs Market Size Market Share by Application (2021-2026)
Figure 40. Germany Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 41. France Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 54. APAC Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 55. Europe Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 57. United States Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 58. Canada Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 59. Mexico Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 60. Brazil Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 61. China Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 62. Japan Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 63. Korea Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 65. India Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 66. Australia Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 67. Germany Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 68. France Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 69. UK Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 70. Italy Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 71. Russia Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 72. Egypt Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 73. South Africa Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 74. Israel Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 75. Turkey Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 76. Global Small Interfering RNA (siRNA) Drugs Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Small Interfering RNA (siRNA) Drugs Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 1. Small Interfering RNA (siRNA) Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Small Interfering RNA (siRNA) Drugs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Small Interfering RNA (siRNA) Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Small Interfering RNA (siRNA) Drugs Sales Market Share by Country/Region (2025)
Figure 8. Small Interfering RNA (siRNA) Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Small Interfering RNA (siRNA) Drugs Market Size Market Share by Type in 2025
Figure 10. Small Interfering RNA (siRNA) Drugs in AHP
Figure 11. Global Small Interfering RNA (siRNA) Drugs Market: AHP (2021-2026) & ($ millions)
Figure 12. Small Interfering RNA (siRNA) Drugs in hATTR
Figure 13. Global Small Interfering RNA (siRNA) Drugs Market: hATTR (2021-2026) & ($ millions)
Figure 14. Small Interfering RNA (siRNA) Drugs in Other
Figure 15. Global Small Interfering RNA (siRNA) Drugs Market: Other (2021-2026) & ($ millions)
Figure 16. Global Small Interfering RNA (siRNA) Drugs Market Size Market Share by Application in 2025
Figure 17. Global Small Interfering RNA (siRNA) Drugs Revenue Market Share by Player in 2025
Figure 18. Global Small Interfering RNA (siRNA) Drugs Market Size Market Share by Region (2021-2026)
Figure 19. Americas Small Interfering RNA (siRNA) Drugs Market Size 2021-2026 ($ millions)
Figure 20. APAC Small Interfering RNA (siRNA) Drugs Market Size 2021-2026 ($ millions)
Figure 21. Europe Small Interfering RNA (siRNA) Drugs Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size 2021-2026 ($ millions)
Figure 23. Americas Small Interfering RNA (siRNA) Drugs Value Market Share by Country in 2025
Figure 24. United States Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Small Interfering RNA (siRNA) Drugs Market Size Market Share by Region in 2025
Figure 29. APAC Small Interfering RNA (siRNA) Drugs Market Size Market Share by Type (2021-2026)
Figure 30. APAC Small Interfering RNA (siRNA) Drugs Market Size Market Share by Application (2021-2026)
Figure 31. China Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 35. India Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Small Interfering RNA (siRNA) Drugs Market Size Market Share by Country in 2025
Figure 38. Europe Small Interfering RNA (siRNA) Drugs Market Size Market Share by Type (2021-2026)
Figure 39. Europe Small Interfering RNA (siRNA) Drugs Market Size Market Share by Application (2021-2026)
Figure 40. Germany Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 41. France Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Small Interfering RNA (siRNA) Drugs Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 54. APAC Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 55. Europe Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 57. United States Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 58. Canada Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 59. Mexico Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 60. Brazil Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 61. China Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 62. Japan Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 63. Korea Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 65. India Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 66. Australia Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 67. Germany Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 68. France Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 69. UK Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 70. Italy Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 71. Russia Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 72. Egypt Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 73. South Africa Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 74. Israel Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 75. Turkey Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
Figure 76. Global Small Interfering RNA (siRNA) Drugs Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Small Interfering RNA (siRNA) Drugs Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Small Interfering RNA (siRNA) Drugs Market Size 2027-2032 ($ millions)
